Amarin Corp Plc (AMRN)

[tke458]

With a few minor exceptions, it’s literally been a straight drop since $8.8 on 2/3.

Tough to watch (and trade as I won’t short) but long term fundamentals are solid

- solid scripts WHEN you consider Covid and generics and the fact that after DU, the US market was written off by many.

- EU CHMP recommendation with approval hopefully in 30ish days.
- China approval late 2021
ROW from there (e.g. Middle East expansion, Russia, etc).
- Covid potential

Then on the aspirational front
- Supreme Court review
- GSK vs Teva decision
- our own case against Hikma
- Marjac etal, efforts (Rule 60)
- always chance of a buyout at these under appreciated values

I’m holding strong (and have bought more at varying levels).